-
Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study.
Pialoux G, Quercia RP, Gahery H, Daniel N, Slama L, Girard PM, Bonnard P, Rozenbaum W, Schneider V, Salmon D, et al.
Clin Vaccine Immunol. 2008 Mar; 15(3):562-8. Epub 2008 Jan 9.
[Clin Vaccine Immunol. 2008]
-
Efficacy, safety and pharmacokinetics of once-daily saquinavir soft-gelatin capsule/ritonavir in antiretroviral-naive, HIV-infected patients.
Montaner JS, Schutz M, Schwartz R, Jayaweera DT, Burnside AF, Walmsley S, Saag MS.
MedGenMed. 2006 May 10; 8(2):36. Epub 2006 May 10.
[MedGenMed. 2006]
-
No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers.
Purkins L, Wood N, Kleinermans D, Love ER.
Br J Clin Pharmacol. 2003 Dec; 56 Suppl 1:62-8.
[Br J Clin Pharmacol. 2003]
- » See all...